selected publications
- The Interplay of Microbiome Dysbiosis and Cardiovascular Disease. Cardiology in review. 2024 Academic Article GET IT
- Immunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity. Clinical liver disease. 2024 Academic Article GET IT
- Disseminated histoplasmosis in an HIV/AIDS transgender male-to-female with atypical and persistent GI manifestations. 2024 GET IT
- Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Is Independently Associated With Reduced Renal Function. Gastro hep advances. 2023 Academic Article GET IT
-
The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection.
Journal of viral hepatitis.
2022
Academic Article
GET IT
Times cited: 12 -
Pregnancy Outcomes After Liver Transplantation: A Systematic Review and Meta-Analysis.
The American journal of gastroenterology.
2021
Review
GET IT
Times cited: 16 -
Risk factors and incidence of 90-day readmission for diverticulitis after an acute diverticulitis index admission.
International journal of colorectal disease.
2020
Academic Article
GET IT
Times cited: 3 -
Portal vein thrombosis prevalence and mortality among alcoholic cirrhosis in a nationwide inpatient cohort.
European journal of gastroenterology & hepatology.
2020
Academic Article
GET IT
Times cited: 8 -
Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence.
Alimentary pharmacology & therapeutics.
2020
Academic Article
GET IT
Times cited: 18 - Colonic Mucosubmucosal Elongated Polyp in the Sigmoid Colon on Surveillance Colonoscopy. 2019 GET IT
-
The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis.
European journal of gastroenterology & hepatology.
2019
Letter
GET IT
Times cited: 2 -
The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis.
European journal of gastroenterology & hepatology.
2018
Review
GET IT
Times cited: 41 -
Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI.
Expert review of gastroenterology & hepatology.
2018
Review
GET IT
Times cited: 40 -
Viral hepatitis screening in transgender patients undergoing gender identity hormonal therapy.
European journal of gastroenterology & hepatology.
2017
Academic Article
GET IT
Times cited: 12 -
Primer on Hepatitis C Virus Resistance to Direct-Acting Antiviral Treatment: A Practical Approach for the Treating Physician.
Clinics in liver disease.
2017
Review
GET IT
Times cited: 5 -
A pangenotypic, single tablet regimen of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection.
Expert opinion on pharmacotherapy.
2017
Review
GET IT
Times cited: 28 -
Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients.
Metabolic brain disease.
2016
Academic Article
GET IT
Times cited: 18 -
Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature.
Breast cancer research and treatment.
2013
Information Resource
GET IT
Times cited: 16 -
Cardiovascular diseases and the liver.
Clinics in liver disease.
2011
Review
GET IT
Times cited: 50 -
Telaprevir: hope on the horizon, getting closer.
Clinics in liver disease.
2009
Review
GET IT
Times cited: 17 - Worth a second look. 2009 GET IT
-
Hepatitis B and end-stage liver disease.
Clinics in liver disease.
2007
Information Resource
GET IT
Times cited: 12 -
Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida.
American journal of medical genetics. Part A.
2003
Academic Article
GET IT
Times cited: 61 -
Characterization of mutations in severe methylenetetrahydrofolate reductase deficiency reveals an FAD-responsive mutation.
Human mutation.
2003
Academic Article
GET IT
Times cited: 50 -
Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease.
Atherosclerosis.
2003
Academic Article
GET IT
Times cited: 75 -
The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine.
Atherosclerosis.
2001
Academic Article
GET IT
Times cited: 333 - The silent T1317C mutation of methylenetetrahydrofolate reductase should not interfere with MboII restriction isotyping of the reported A1298C mutation. Molecular genetics and metabolism. 1999 Academic Article GET IT
-
A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity.
Molecular genetics and metabolism.
1998
Academic Article
GET IT
Times cited: 1155